A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 2	2026-09-10		NCT07766018

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Stemline Therapeutics, Inc.	22

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chiba Cancer Center	Chiba	Japan	4
Juntendo University Hospital	Tokyo	Japan	12
Kumamoto Shinto General Hospital	Kumamoto	Japan	2
Kumamoto University Hospital	Kumamoto	Japan	8
Kyushu University Hospital	Fukuoka	Japan	20
National Hospital Organization - Hokkaido Cancer Center	Sapporo	Japan	1
National Hospital Organization - Kyushu Medical Center	Fukuoka	Japan	1
National Hospital Organization - Osaka National Hospital	Osaka	Japan	1
Saitama Cancer Center	Ina	Japan	1
The Cancer Institute Hospital of JFCR (Japanese Foundation For Cancer Research)	Kōtō City	Japan	1
Tokai University Hospital	Isehara	Japan	2